Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: kha vu who wrote (58875)	9/1/1999 1:19:00 AM
From: Bo Didley	Read Replies (2) \| Respond to of 120523

kha vu ---- did you see GUMM today ?? Our long term investment is starting to catch notice of some large buyers. The OTC common cold market is nearly a $3 billion industry and Zicam is the best remedy for the cold. Cold Season is coming up and smart investors are buying now, but smarter ones bought earlier<g>. Here is a person who also thinks GUMM is the next KIDE in the making. Message 11122280 It was Street Walker who did the analysis on KIDE early on. I'm going all out on his GUMM pick. Everyone who reads this thread will most likely catch a cold or two this year. Have Zicam in your medicine cabinet to reduce your cold to 1-3 days. Available in 30,000-50,000 stores very soon! Cost is around $10.50 and GUMM's profit margins are 58%. An investors dream! bo